IP Library Granted Patent US 12690381
Granted Patent B2
US 12690381 · App. 18/289,449 · Granted Jul 21, 2026

Organometallic compound and application thereof

Inventors: Liangliang Yan (Foshan, CN); Shaofu Chen (Foshan, CN); Lei Dai (Foshan, CN); Lifei Cai (Foshan, CN)
Assignee: SICHUAN AG-RAY NEW MATERIALS CO., LTD
H10K85/00C07F15/0033C09K11/06H10K85/342C09K2211/1029C09K2211/1033C09K2211/185H10K50/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12690381
App. No.
18/289,449
Granted
Jul 21, 2026
Kind
B2
Abstract

The present invention relates to an organometallic compound and application thereof. The organometallic compound has a general formula of Ir(La)(Lb)(Lc), where La is a structure represented by Formula (1), and Lb is a structure represented by Formula (2). The compound provided by the present invention has the advantages of high optical and electrical stability, low sublimation temperature, narrow emission half-peak width, high color saturation, high luminous efficiency, long device service life and the like, and can be used in organic electroluminescent devices. In particular, the compound has the potential for application in the AMOLED industry as a red light-emitting dopant.

Claims (45)

1 . An organometallic compound, having a general formula of Ir(La)(Lb)(Lc), wherein La is a structure represented by Formula (1):

wherein dotted lines refer to positions connected to the metal Ir;

X 1 is N or CR 1 , X 2 is N or CR 2 , X 3 is N or CR 3 , X 4 is N or CR 4 , and X 5 is N or CR 5 ;

at most one of the X 1 -X 5 is N, and when the X 1 -X 5 are CR 1 -CR 5 , at least one of the R 1 -R 5 is not H;

R 1 -R 10 are independently selected from hydrogen, deuterium, halogen, cyano, hydroxyl, sulfhydryl, amino, substituted or unsubstituted C 1 -C 10 alkyl, substituted or unsubstituted C 1 -C 10 heteroalkyl, substituted or unsubstituted C 3 -C 20 cycloalkyl, substituted or unsubstituted C 2 -C 10 alkenyl, substituted or unsubstituted C 2 -C 10 alkynyl, substituted or unsubstituted C 6 -C 18 aryl, substituted or unsubstituted C 2 -C 17 heteroaryl, substituted or unsubstituted tri-C 1 -C 10 alkyl silyl, substituted or unsubstituted tri-C 6 -C 12 aryl silyl, substituted or unsubstituted di-C 1 -C 10 alkyl mono-C 6 -C 30 aryl silyl, or substituted or unsubstituted mono-C 1 -C 10 alkyl di-C 6 -C 30 aryl silyl, or any two adjacent groups of the R 1 -R 6 or R 7 -R 10 may be connected to each other to form an aliphatic ring structure or an aromatic ring structure; at least one of the R 7 -R 10 is not hydrogen; the “substituted” refers to substitution with deuterium, F, Cl, Br, C 1 -C 6 alkyl, C 3 -C 6 cycloalkyl, C 1 -C 6 alkoxyl, amino substituted with C 1 -C 6 alkyl, cyano, isocyano, or phosphino, and the substitution ranges from a single substitution number to a maximum substitution number; and the heteroalkyl and the heteroaryl contain at least one O, N or S heteroatom;

Lb is a structure represented by Formula (2):

wherein dotted lines refer to positions connected to the metal Ir;

Ra-Rg are independently selected from hydrogen, deuterium, halogen, substituted or unsubstituted C 1 -C 10 alkyl, substituted or unsubstituted C 3 -C 20 cycloalkyl, substituted or unsubstituted C 1 -C 10 heteroalkyl, or substituted or unsubstituted C 3 -C 20 heterocyclic alkyl; or any two of Ra, Rb and Rc are connected to form an aliphatic ring structure, and any two of Re, Rf and Rg are connected o form an aliphatic ring structure; the “substituted” refers to substitution with deuterium, F, Cl, Br, C 1 -C 4 alkyl, C 1 -C 4 alkoxyl, C 3 -C 6 cycloalkyl, amino substituted with C 1 -C 4 alkyl, cyano, isocyano, or phosphino;

and the heteroalkyl and the heterocyclic alkyl at least contain one O, N or S heteroatom;

Lc is a monoanionic bidentate ligand, and the Lc is different from the Lb and is not an OO ligand;

the Lc and the La are the same or different, and the different indicates different parent nuclear structures, a same parent nuclear structure with different substituents, or a same parent nuclear structure with different substituent positions;

or any two or three of the La, the Lb and the Lc are connected to each other to form a polydentate ligand.

2 . The organometallic compound according to claim 1 , wherein the La is a structure represented by Formula (3):

wherein dotted lines refer to positions connected to the metal Ir;

R 1 -R 10 are independently selected from hydrogen, deuterium, halogen, cyano, hydroxyl, sulfhydryl, amino, substituted or unsubstituted C 1 -C 10 alkyl, substituted or unsubstituted C 1 -C 10 heteroalkyl, substituted or unsubstituted C 3 -C 20 cycloalkyl, substituted or unsubstituted C 2 -C 10 alkenyl, substituted or unsubstituted C 2 -C 10 alkynyl, substituted or unsubstituted C 6 -C 18 aryl, substituted or unsubstituted C 2 -C 17 heteroaryl, substituted or unsubstituted tri-C 1 -C 10 alkyl silyl, substituted or unsubstituted tri-C 6 -C 12 aryl silyl, substituted or unsubstituted di-C 1 -C 10 alkyl mono-C 6 -C 30 aryl silyl, or substituted or unsubstituted mono-C 1 -C 10 alkyl di-C 6 -C 30 aryl silyl; or any two adjacent groups of the R 1 -R 6 or R 7 -R 10 are connected to each other to form an aliphatic ring structure or an aromatic ring structure;

at least one of the R 7 -R 10 is not hydrogen;

the heteroalkyl and the heteroaryl at least contain one O, N or S heteroatom;

and the “substituted” refers to substitution with deuterium, F, Cl, Br, C 1 -C 6 alkyl, C 3 -C 6 cycloalkyl, C 1 -C 6 alkoxyl, amino substituted with C 1 -C 6 alkyl, cyano, isocyano, or phosphino, and the substitution ranges from a single substitution number to a maximum substitution number.

3 . The organometallic compound according to claim 2 , wherein in Formula (3), the R 1 and/or the R 4 and/or the R 5 is not hydrogen.

4 . The organometallic compound according to claim 3 , wherein in Formula (3), the R 2 and the R 3 are hydrogen.

5 . The organometallic compound according to claim 4 , wherein in Formula (3), the R 1 , the R 4 and the R 5 are independently selected from deuterium, halogen, substituted or unsubstituted C 1 -C 6 alkyl, or substituted or unsubstituted C 3 -C 10 cycloalkyl, and the “substituted” refers to substitution with deuterium, F, Cl, Br, or C 1 -C 4 alkyl.

6 . The organometallic compound according to claim 2 , wherein in Formula (3), the R 6 is selected from deuterium, halogen, substituted or unsubstituted C 1 -C 6 alkyl, or substituted or unsubstituted C 3 -C 10 cycloalkyl; and the R 5 and/or the R 10 is not hydrogen.

7 . The organometallic compound according to claim 6 , wherein in Formula (3), the R 8 and the R 10 are independently selected from substituted or unsubstituted C 1 -C 6 alkyl, or substituted or unsubstituted C 3 -C 10 cycloalkyl, and the “substituted” refers to substitution with deuterium, F, Cl, Br, or C 1 -C 4 alkyl.

8 . The organometallic compound according to claim 2 , wherein in Formula (3), the R 7 and the R 9 are H.

9 . The organometallic compound according to claim 2 , wherein the R 7 and the R 8 , the R 8 and the R 9 , or the R 9 and the R 10 are connected to each other to form a structure represented by Formula (4):

wherein * indicates a connecting position;

Y 1 -Y 4 are independently CR 0 or N;

Z1 is selected from O or S;

R 0 is independently hydrogen, deuterium, halogen, cyano, substituted or unsubstituted C 1 -C 10 alkyl, substituted or unsubstituted C 3 -C 20 cycloalkyl, substituted or unsubstituted C 2 -C 30 alkenyl, substituted or unsubstituted C 2 -C 30 alkynyl, substituted or unsubstituted C 6 -C 30 aryl, substituted or unsubstituted C 1 -C 30 heteroaryl, substituted or unsubstituted tri-C 1 -C 10 alkyl silyl, substituted or unsubstituted tri-C 6 -C 30 aryl silyl, or substituted or unsubstituted di-C 1 -C 10 alkyl mono-C 6 -C 30 aryl silyl; and the “substituted” refers to substitution with deuterium, F, Cl, Br, C 1 -C 4 alkyl, C 1 -C 4 alkoxyl, C 3 -C 6 cycloalkyl, amino substituted with C 1 -C 4 alkyl, cyano, isocyano, or phosphino.

10 . The organometallic compound according to claim 9 , wherein in Formula (4), the Y 1 -Y 4 are independently CR 0 , the Z1 is O, and the R 0 is independently hydrogen, deuterium, halogen, substituted or unsubstituted C 1 -C 6 alkyl, or substituted or unsubstituted C 3 -C 10 cycloalkyl; and the “substituted” refers to substitution with deuterium, F, Cl, Br, or C 1 -C 4 alkyl.

11 . The organometallic compound according to claim 1 , wherein the Lc and the La are the same.

12 . The organometallic compound according to claim 1 , wherein the Lc is a structure represented by Formula (5):

wherein dotted lines refer to positions connected to the metal Ir;

R 11 -R 18 are independently selected from hydrogen, deuterium, halogen, cyano, hydroxyl, amino group, amino, substituted or unsubstituted C 1 -C 10 alkyl, substituted or unsubstituted C 1 -C 10 heteroalkyl, substituted or unsubstituted C 3 -C 20 cycloalkyl, substituted or unsubstituted C 2 -C 10 alkenyl, substituted or unsubstituted C 2 -C 10 alkynyl, substituted or unsubstituted C 6 -C 18 aryl, substituted or unsubstituted C 2 -C 17 heteroaryl, substituted or unsubstituted tri-C 1 -C 10 alkyl silyl, substituted or unsubstituted tri-C 6 -C 12 aryl silyl, substituted or unsubstituted di-C 1 -C 10 alkyl mono-C 6 -C 30 aryl silyl, or substituted or unsubstituted mono-C 1 -C 10 alkyl di-C 6 -C 30 aryl silyl; at least two of the R 15 -R 18 are not hydrogen;

at least two adjacent groups of the R 11 -R 14 form an aromatic ring structure represented by the following Formula (6):

wherein dotted lines refer to positions connected to a pyridine ring;

R 19 -R 22 are independently selected from hydrogen, deuterium, halogen, cyano, substituted or unsubstituted C 1 -C 10 alkyl, substituted or unsubstituted C 1 -C 10 heteroalkyl, substituted or unsubstituted C 3 -C 20 cycloalkyl, substituted or unsubstituted C 2 -C 10 alkenyl, substituted or unsubstituted C 2 -C 10 alkynyl, substituted or unsubstituted C 6 -C 18 aryl, substituted or unsubstituted C 2 -C 17 heteroaryl, substituted or unsubstituted tri-C 1 -C 10 alkyl silyl, substituted or unsubstituted tri-C 6 -C 12 aryl silyl, substituted or unsubstituted di-C 1 -C 10 alkyl mono-C 6 -C 30 aryl silyl, or substituted or unsubstituted mono-C 1 -C 10 alkyl di-C 6 -C 30 aryl silyl, or any two adjacent groups of the R 19 -R 22 are connected to each other to form an aliphatic ring structure or an aromatic ring structure;

and the “substituted” refers to substitution with deuterium, F, Cl, Br, C 1 -C 4 alkyl, C 1 -C 4 alkoxyl, C 3 -C 6 cycloalkyl, amino substituted with C 1 -C 4 alkyl, cyano, isocyano, or phosphino.

13 . The organometallic compound according to claim 12 , wherein the R 15 and the R 17 are deuterium, halogen, substituted or unsubstituted C 1 -C 6 alkyl, or substituted or unsubstituted C 3 -C 10 cycloalkyl, two adjacent groups of the R 11 -R 14 form an aromatic ring structure represented by Formula (6), and the other two groups are independently selected from hydrogen, deuterium, halogen, substituted or unsubstituted C 1 -C 6 alkyl, or substituted or unsubstituted C 3 -C 10 cycloalkyl;

the R 19 -R 22 are independently selected from hydrogen, deuterium, halogen, substituted or unsubstituted C 1 -C 6 alkyl, or substituted or unsubstituted C 3 -C 10 cycloalkyl; and the “substituted” refers to substitution with deuterium, F, Cl, Br, or C 1 -C 4 alkyl.

14 . The organometallic compound according to claim 2 , wherein the La has one of the following structural formulas, or one of the following structural formulas in which the hydrogen atom(s) is/are partially or completely deuterated, or one of the following structural formulas in which the hydrogen atom(s) is/are partially or completely fluorinated,

15 . The organometallic compound according to claim 2 , wherein the Lb has one of the following structural formulas, or one of the following structural formulas in which the hydrogen atom(s) is/are partially or completely deuterated, or one of the following structural formulas in which the hydrogen atom(s) is/are partially or completely fluorinated,

16 . The organometallic compound according to claim 12 , wherein the Lc has one of the following structural formulas, or is partially or completely deuterated or fluorinated correspondingly,

17 . An organicelectroluminescent device, wherein the device comprises the organometallic compound of claim 1 .

18 . The organicelectroluminescent device of claim 17 , comprising a light-emitting layer, wherein the light-emitting layer comprises the organometallic compound of claim 1 .